Attached files
| file | filename |
|---|---|
| EX-4.1 - EX-4.1 - ANI PHARMACEUTICALS INC | anip-20201231ex418bc77a4.htm |
| EX-32.1 - EX-32.1 - ANI PHARMACEUTICALS INC | anip-20201231ex321a7aacd.htm |
| EX-31.2 - EX-31.2 - ANI PHARMACEUTICALS INC | anip-20201231ex312e722ef.htm |
| EX-31.1 - EX-31.1 - ANI PHARMACEUTICALS INC | anip-20201231ex311ab6e5c.htm |
| EX-21 - EX-21 - ANI PHARMACEUTICALS INC | anip-20201231ex215e26aad.htm |
| EX-10.20 - EX-10.20 - ANI PHARMACEUTICALS INC | anip-20201231ex1020e9a9d.htm |
| 10-K - 10-K - ANI PHARMACEUTICALS INC | anip-20201231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of ANI Pharmaceuticals, Inc. on Form S-3 (No. 333-239771) and on Form S-8 (Nos. 333-196518, 333-214416, 333-218120, and 333-250892) of our reports dated March 11, 2021, on our audits of the consolidated financial statements as of December 31, 2020 and 2019 and for each of the years in the three-year period ended December 31, 2020, and the effectiveness of ANI Pharmaceuticals, Inc. and Subsidiaries’ internal control over financial reporting as of December 31, 2020, which reports are included in this Annual Report on Form 10-K to be filed on or about March 11, 2021.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Philadelphia, Pennsylvania
March 11, 2021